Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
暂无分享,去创建一个
K. Duffin | A. Sanyal | R. Loomba | M. Hartman | D. Robins | A. Haupt | C. Karanikas | J. Wilson | R. Bray | Jonathan M. Wilson | A. Nikooienejad | Amir Nikooienejad